NasdaqIndustrialsServices-Testing LaboratoriesROCKVILLE, MD

20/20 Biolabs, Inc. AIDX

Ask your AI

Estimated market cap $2.61M12.77M shares, shares as of Aug 14, 2026CIK 1139685

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

1.5% of shares · 3 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q2 2026

What changed in 20/20 Biolabs, Inc.'s latest quarterly report, compared with the one before.

Filed Aug 14, 2026 · Quarter ended Jun 30, 2026

Compared with the 10-Q for the quarter ended Mar 31, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in 20/20 Biolabs, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No recent insider purchases or sales for this company.

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

191,119 shares

12 funds report AIDX. Values checked against market prices.

Funds own 5.1% of shares (Q2 2026)

15 funds hold the stock.

Q3 2026: 1.5% · 5,560 of ~8,900 funds reported so far

Q1 20262.9%
Q2 20265.1%
Q3 2026 (so far)1.5%

Q3 2026. 2 new, 3 added to, 0 trimmed, 5 exited since Q2 2026.

Top 13F holders
#
1	Geode Capital Management, LLC 13F ↗	54,493	$23.8K	+10.9%
2	Vanguard Fiduciary Trust Co 13F ↗	52,087	$22.8K	unchanged
3	Atlantic Union Bankshares Corp 13F ↗	35,099	$15.3K	unchanged
4	Vanguard Capital Management LLC 13F ↗	29,530	$12.9K	+20.4%
5	HRT Financial LP 13F ↗	14,869	$6,000	n/a
6	McDonald Partners LLC 13F ↗	2,800	$1,222	unchanged
7	Signaturefd, LLC 13F ↗	767	$335	unchanged
8	UBS Group AG 13F ↗	580	$252	+19233.3%
9	Osaic Holdings, Inc. 13F ↗	438	$192	New
10	Morgan Stanley 13F ↗	283	$124	unchanged

One of these funds reports its values in thousands of dollars; its figures are shown in dollars.

Download CSV Every fund that holds AIDX, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What 20/20 Biolabs, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What 20/20 Biolabs, Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2026	7	—	300,425	$564.8K
Q2 2026	15	+8	540,620	$297.1K
Q3 2026	12	-3	191,119	$83.0K

Each point is a quarter-end, from Q1 2026 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (90138K101). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2026) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes3 in 12 mo 8-K events5 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record IPO history2 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: 20/20 Biolabs, Inc.
Address: 9430 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD 20850
Phone: 2404536339
Fiscal year ends: Dec 31
Filer category: emerging growth company
Incorporated in: DE
Listed as: AIDX (Nasdaq)
Former names: 20/20 GeneSystems, Inc. (until 2025); 20/20 GENE SYSTEMS INC (until 2004)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$0.2043+$0.00 (+0.25%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $0.1869 · High $0.3513Nov 13, 2026

Aug 13, 2026Low $0.1869 · High $0.6304Nov 13, 2026

Feb 19, 2026Low $0.1869 · High $23.85Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.